9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma

Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma

Estimated reading time: < 1 min

Condition: Malignant Mesothelioma

Estimated Enrollment: 30

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: No Results Available

Outcome Measures: ,  ,  ,

Interventions: liposomal NDDP, therapeutic thoracoscopy

Phase:

Study Type: Interventional

Study Design: Primary Purpose: Treatment, , ,

Primary Completion Date: May 2001

Completion Date:

Last  Posted Date: March 28, 2011

Location: NYU School of Medicine’s Kaplan Comprehensive Cancer Center, New York, New York, United States

Website Link: https://ClinicalTrials.gov/show/NCT00004033

Was this article helpful?
Dislike 0